Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-048641

Director sold 4,730 shares at $26.91 ($127,284)

  • Director acquired 4,096 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Welgus Howard G. Director 2026-07-15 Option exercise 10b5-1 +822 $6.52 $5,361 38,565 D: show line 1 in the form
Welgus Howard G. Director 2026-07-15 Option exercise 10b5-1 +1,019 $7.51 $7,653 39,584 D: show line 2 in the form
Welgus Howard G. Director 2026-07-15 Option exercise 10b5-1 +2,255 $8.63 $19,461 41,839 D: show line 3 in the form
Welgus Howard G. Director 2026-07-15 Sale 10b5-1 −4,730 $26.91 $127,284 37,109 D: show line 4 in the form
Open-market sales · 4,730 sh · avg $26.91 · $127,284

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Welgus Howard G. Director 2026-07-15 Option exercise · Stock Option (right to buy) 10b5-1 −822 8,218 D: show line 5 in the form
Welgus Howard G. Director 2026-07-15 Option exercise · Stock Option (right to buy) 10b5-1 −1,019 10,182 D: show line 6 in the form
Welgus Howard G. Director 2026-07-15 Option exercise · Stock Option (right to buy) 10b5-1 −2,255 22,542 D: show line 7 in the form
Loading xslF345X06/wk-form4_1784318483.xml…